405 related articles for article (PubMed ID: 10594070)
1. Neurochemical and cellular reorganization of the spinal cord in a murine model of bone cancer pain.
Schwei MJ; Honore P; Rogers SD; Salak-Johnson JL; Finke MP; Ramnaraine ML; Clohisy DR; Mantyh PW
J Neurosci; 1999 Dec; 19(24):10886-97. PubMed ID: 10594070
[TBL] [Abstract][Full Text] [Related]
2. Murine models of inflammatory, neuropathic and cancer pain each generates a unique set of neurochemical changes in the spinal cord and sensory neurons.
Honore P; Rogers SD; Schwei MJ; Salak-Johnson JL; Luger NM; Sabino MC; Clohisy DR; Mantyh PW
Neuroscience; 2000; 98(3):585-98. PubMed ID: 10869852
[TBL] [Abstract][Full Text] [Related]
3. Osteoprotegerin diminishes advanced bone cancer pain.
Luger NM; Honore P; Sabino MA; Schwei MJ; Rogers SD; Mach DB; Clohisy DR; Mantyh PW
Cancer Res; 2001 May; 61(10):4038-47. PubMed ID: 11358823
[TBL] [Abstract][Full Text] [Related]
4. Bone cancer induces a unique central sensitization through synaptic changes in a wide area of the spinal cord.
Yanagisawa Y; Furue H; Kawamata T; Uta D; Yamamoto J; Furuse S; Katafuchi T; Imoto K; Iwamoto Y; Yoshimura M
Mol Pain; 2010 Jul; 6():38. PubMed ID: 20602757
[TBL] [Abstract][Full Text] [Related]
5. Tumor-induced injury of primary afferent sensory nerve fibers in bone cancer pain.
Peters CM; Ghilardi JR; Keyser CP; Kubota K; Lindsay TH; Luger NM; Mach DB; Schwei MJ; Sevcik MA; Mantyh PW
Exp Neurol; 2005 May; 193(1):85-100. PubMed ID: 15817267
[TBL] [Abstract][Full Text] [Related]
6. Simultaneous reduction in cancer pain, bone destruction, and tumor growth by selective inhibition of cyclooxygenase-2.
Sabino MA; Ghilardi JR; Jongen JL; Keyser CP; Luger NM; Mach DB; Peters CM; Rogers SD; Schwei MJ; de Felipe C; Mantyh PW
Cancer Res; 2002 Dec; 62(24):7343-9. PubMed ID: 12499278
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms that generate and maintain bone cancer pain.
Mantyh PW; Hunt SP
Novartis Found Symp; 2004; 260():221-38; discussion 238-40, 277-9. PubMed ID: 15283453
[TBL] [Abstract][Full Text] [Related]
8. Theta-Burst Stimulation of Primary Afferents Drives Long-Term Potentiation in the Spinal Cord and Persistent Pain via α2δ-1-Bound NMDA Receptors.
Huang Y; Chen SR; Chen H; Zhou JJ; Jin D; Pan HL
J Neurosci; 2022 Jan; 42(3):513-527. PubMed ID: 34880118
[TBL] [Abstract][Full Text] [Related]
9. Bone cancer pain.
Clohisy DR; Mantyh PW
Cancer; 2003 Feb; 97(3 Suppl):866-73. PubMed ID: 12548588
[TBL] [Abstract][Full Text] [Related]
10. A mechanism-based understanding of bone cancer pain.
Mantyh PW
Novartis Found Symp; 2004; 261():194-214; discussion 214-9, 256-61. PubMed ID: 15469052
[TBL] [Abstract][Full Text] [Related]
11. Protease-activated receptor 2 in dorsal root ganglion contributes to peripheral sensitization of bone cancer pain.
Liu S; Liu YP; Yue DM; Liu GJ
Eur J Pain; 2014 Mar; 18(3):326-37. PubMed ID: 23893658
[TBL] [Abstract][Full Text] [Related]
12. Role of nitric oxide synthase in the development of bone cancer pain and effect of L-NMMA.
Yang Y; Zhang J; Liu Y; Zheng Y; Bo J; Zhou X; Wang J; Ma Z
Mol Med Rep; 2016 Feb; 13(2):1220-6. PubMed ID: 26648027
[TBL] [Abstract][Full Text] [Related]
13. Cancer pain and neuropathic pain are associated with A β sensory neuronal plasticity in dorsal root ganglia and abnormal sprouting in lumbar spinal cord.
Zhu YF; Kwiecien JM; Dabrowski W; Ungard R; Zhu KL; Huizinga JD; Henry JL; Singh G
Mol Pain; 2018; 14():1744806918810099. PubMed ID: 30324862
[TBL] [Abstract][Full Text] [Related]
14. Osteoprotegerin blocks bone cancer-induced skeletal destruction, skeletal pain and pain-related neurochemical reorganization of the spinal cord.
Honore P; Luger NM; Sabino MA; Schwei MJ; Rogers SD; Mach DB; O'keefe PF; Ramnaraine ML; Clohisy DR; Mantyh PW
Nat Med; 2000 May; 6(5):521-8. PubMed ID: 10802707
[TBL] [Abstract][Full Text] [Related]
15. Cancer pain is not necessarily correlated with spinal overexpression of reactive glia markers.
Ducourneau VRR; Dolique T; Hachem-Delaunay S; Miraucourt LS; Amadio A; Blaszczyk L; Jacquot F; Ly J; Devoize L; Oliet SHR; Dallel R; Mothet JP; Nagy F; Fénelon VS; Voisin DL
Pain; 2014 Feb; 155(2):275-291. PubMed ID: 24120461
[TBL] [Abstract][Full Text] [Related]
16. Different tumors in bone each give rise to a distinct pattern of skeletal destruction, bone cancer-related pain behaviors and neurochemical changes in the central nervous system.
Sabino MA; Luger NM; Mach DB; Rogers SD; Schwei MJ; Mantyh PW
Int J Cancer; 2003 May; 104(5):550-8. PubMed ID: 12594809
[TBL] [Abstract][Full Text] [Related]
17. Alteration of cancer pain-related signals by radiation: proteomic analysis in an animal model with cancer bone invasion.
Park HC; Seong J; An JH; Kim J; Kim UJ; Lee BW
Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1523-34. PubMed ID: 15817359
[TBL] [Abstract][Full Text] [Related]
18. Cellular and neurochemical remodeling of the spinal cord in bone cancer pain.
Honoré P; Schwei J; Rogers SD; Salak-Johnson JL; Finke MP; Ramnaraine ML; Clohisy DR; Mantyh PW
Prog Brain Res; 2000; 129():389-97. PubMed ID: 11098706
[No Abstract] [Full Text] [Related]
19. Bone cancer pain: from mechanism to model to therapy.
Honore P; Mantyh PW
Pain Med; 2000 Dec; 1(4):303-9. PubMed ID: 15101876
[TBL] [Abstract][Full Text] [Related]
20. CXCL12 in astrocytes contributes to bone cancer pain through CXCR4-mediated neuronal sensitization and glial activation in rat spinal cord.
Shen W; Hu XM; Liu YN; Han Y; Chen LP; Wang CC; Song C
J Neuroinflammation; 2014 Apr; 11():75. PubMed ID: 24735601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
